REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pharmaca S.R.O. (Czech Republic)

Main Activities: Department Stores
Full name: Pharmaca S.R.O. Profile Updated: December 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Pharmaca S.R.O. is a company in Czech Republic, with a head office in Ceske Budejovice. The company operates in the Department Stores industry. It was incorporated on April 25, 2006. It currently has a total number of 25 - 49 (2023) employees. From the latest financial highlights, Pharmaca S.R.O. reported a net sales revenue increase of 5.27% in 2023. Its’ total assets recorded a growth of 21.97%. In 2023, Pharmaca S.R.O.’s net profit margin increased by 1.21%.

Headquarters
B. Nemcove 610/39
Ceske Budejovice; Jihocesky; Postal Code: 37001

Contact Details: Purchase the Pharmaca S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmaca S.R.O. report to view the information.
Outstanding Shares:
Purchase the Pharmaca S.R.O. report to view the information.
Registered Capital:
Purchase the Pharmaca S.R.O. report to view the information.
Incorporation Date:
April 25, 2006
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Subsidiaries
T H O W T S.R.O.
100%
Company Performance
Financial values in the chart are available after Pharmaca S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
5.27%▲
Total operating revenue
5.18%▲
Operating profit (EBIT)
13.31%▲
EBITDA
12.96%▲
Net Profit (Loss) for the Period
22.75%▲
Total assets
21.97%▲
Total equity
43.31%▲
Operating Profit Margin (ROS)
0.71%▲
Net Profit Margin
1.21%▲
Return on Equity (ROE)
-5.07%▼
Debt to Equity Ratio
-18.38%▼
Quick Ratio
0.13%▲
Cash Ratio
-0.24%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo